Dr Reddy’s Laboratories (RDY) has released an update.
Dr. Reddy’s Laboratories Ltd. has announced an upcoming investor call to discuss the acquisition of the global brand Nicotinell and related brands from Haleon plc, which is slated for June 26, 2024. The call aims to provide a platform for management to detail the acquisition’s implications and future plans. It reflects the company’s ongoing commitment to expanding its product portfolio and enhancing shareholder value.
For further insights into RDY stock, check out TipRanks’ Stock Analysis page.
